Multivessel Disease from Reasonably Incomplete to Functionally Complete Revascularization
Soon after the introduction of coronary artery bypass surgery, the "completeness" of revascularization became a matter of concern. Several early surgical studies confirmed the belief that better clinical outcomes were obtained when each and every angiographically visible stenosis was bypassed by a distal anastomosis.1,2 Similarly, among patients with multivessel disease treated with percutaneous coronary intervention (PCI), complete revascularization was found to provide a significant advantage over incomplete revascularization in terms of re-intervention, myocardial infarction and death.3,4 However, a careful analysis of surgically treated multivessel disease patients in the BARI trial showed that one graft to any system other than the LAD confers no long-term advantage over PCI and may actually be deleterious.5 (SELECT FULL TEXT TO CONTINUE)
- acute coronary syndrome
- fractional flow reserve
- percutaneous transluminal coronary angioplasty
- incomplete revascularization
- Received April 16, 2012.
- Accepted April 17, 2012.
- Copyright © 2012, American Heart Association, Inc. All rights reserved. Unauthorized use prohibited